Excretion connection VMA-99-82 — a novel adenine having antiviral activity
In the study of excretion of the drug established that VMA-99-82 detected in the urine for at least 72 hours of the study. Renal clearance was 0.936 ml/hr, extrarenal — 666.04 ml/h by intravenous route of administration, 1.8 ml/hr and 1009.72 ml/h, respectively, by the oral route of administration....
Saved in:
| Main Authors: | , , , , , |
|---|---|
| Format: | Article |
| Language: | Russian |
| Published: |
LLC “Publisher OKI”
2013-04-01
|
| Series: | Фармакокинетика и Фармакодинамика |
| Subjects: | |
| Online Access: | https://www.pharmacokinetica.ru/jour/article/view/129 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1850062574456930304 |
|---|---|
| author | L. A. Smirnova E. A. Suchkov A. F. Ryabukha K. A. Kuznetsov A. A. Ozerov A. V. Karavaev |
| author_facet | L. A. Smirnova E. A. Suchkov A. F. Ryabukha K. A. Kuznetsov A. A. Ozerov A. V. Karavaev |
| author_sort | L. A. Smirnova |
| collection | DOAJ |
| description | In the study of excretion of the drug established that VMA-99-82 detected in the urine for at least 72 hours of the study. Renal clearance was 0.936 ml/hr, extrarenal — 666.04 ml/h by intravenous route of administration, 1.8 ml/hr and 1009.72 ml/h, respectively, by the oral route of administration. Superiority over the renal clearance extrarenal correlates with earlier data on the distribution of the compound VMA-99-82 in organs and tissues. The drug was determined in the kidney in low concentrations and by intravenous and oral routes of administration. Tissue availability was 0,452 and 0,413 in intravenous and oral routes of administration, respectively. Win unmodified substance elimination of the administered dose is less than 1%, and its amount in the feces is about 5 times lower than that in the urine. In this regard, we can assume an intense flow of processes of biotransformation. |
| format | Article |
| id | doaj-art-a4419157a00441dfb2de4c95fa20e861 |
| institution | DOAJ |
| issn | 2587-7836 2686-8830 |
| language | Russian |
| publishDate | 2013-04-01 |
| publisher | LLC “Publisher OKI” |
| record_format | Article |
| series | Фармакокинетика и Фармакодинамика |
| spelling | doaj-art-a4419157a00441dfb2de4c95fa20e8612025-08-20T02:49:52ZrusLLC “Publisher OKI”Фармакокинетика и Фармакодинамика2587-78362686-88302013-04-01014042128Excretion connection VMA-99-82 — a novel adenine having antiviral activityL. A. Smirnova0E. A. Suchkov1A. F. Ryabukha2K. A. Kuznetsov3A. A. Ozerov4A. V. Karavaev5Institute of Pharmacology, Volgograd Medical UniversityInstitute of Pharmacology, Volgograd Medical UniversityInstitute of Pharmacology, Volgograd Medical UniversityInstitute of Pharmacology, Volgograd Medical UniversityInstitute of Pharmacology, Volgograd Medical UniversityInstitute of Pharmacology, Volgograd Medical UniversityIn the study of excretion of the drug established that VMA-99-82 detected in the urine for at least 72 hours of the study. Renal clearance was 0.936 ml/hr, extrarenal — 666.04 ml/h by intravenous route of administration, 1.8 ml/hr and 1009.72 ml/h, respectively, by the oral route of administration. Superiority over the renal clearance extrarenal correlates with earlier data on the distribution of the compound VMA-99-82 in organs and tissues. The drug was determined in the kidney in low concentrations and by intravenous and oral routes of administration. Tissue availability was 0,452 and 0,413 in intravenous and oral routes of administration, respectively. Win unmodified substance elimination of the administered dose is less than 1%, and its amount in the feces is about 5 times lower than that in the urine. In this regard, we can assume an intense flow of processes of biotransformation.https://www.pharmacokinetica.ru/jour/article/view/129производные аденинаэкскрецияadenine derivatives excretion |
| spellingShingle | L. A. Smirnova E. A. Suchkov A. F. Ryabukha K. A. Kuznetsov A. A. Ozerov A. V. Karavaev Excretion connection VMA-99-82 — a novel adenine having antiviral activity Фармакокинетика и Фармакодинамика производные аденина экскреция adenine derivatives excretion |
| title | Excretion connection VMA-99-82 — a novel adenine having antiviral activity |
| title_full | Excretion connection VMA-99-82 — a novel adenine having antiviral activity |
| title_fullStr | Excretion connection VMA-99-82 — a novel adenine having antiviral activity |
| title_full_unstemmed | Excretion connection VMA-99-82 — a novel adenine having antiviral activity |
| title_short | Excretion connection VMA-99-82 — a novel adenine having antiviral activity |
| title_sort | excretion connection vma 99 82 a novel adenine having antiviral activity |
| topic | производные аденина экскреция adenine derivatives excretion |
| url | https://www.pharmacokinetica.ru/jour/article/view/129 |
| work_keys_str_mv | AT lasmirnova excretionconnectionvma9982anoveladeninehavingantiviralactivity AT easuchkov excretionconnectionvma9982anoveladeninehavingantiviralactivity AT afryabukha excretionconnectionvma9982anoveladeninehavingantiviralactivity AT kakuznetsov excretionconnectionvma9982anoveladeninehavingantiviralactivity AT aaozerov excretionconnectionvma9982anoveladeninehavingantiviralactivity AT avkaravaev excretionconnectionvma9982anoveladeninehavingantiviralactivity |